Azienda Ospedaliera G.Salvini Ospedale di Rho

Rho

0 studies enrolling now · 5 studies all time

What they study most

Crohn Disease, Fistulizing Crohns Disease, Perianal Crohns Disease, Ulcerative Colitis

Studies at this site

• A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease — Stopped early